IRB Advisor – June 1, 2008
June 1, 2008
View Issues
-
Know various state regulations to avoid obstacles during IRB process
IRBs often are involved with studies that involve sites in other states, which raise a host of concerns and complications. -
Study analyzes impact of investigator attendance on IRB review efficiency
IRB members have different opinions and policies on whether to permit investigators to attend IRB meetings. But are these policies based on any evidence that one way works better than another? -
Research site obtains informed consent at each and every visit
When IRBs approve a clinical trial site's informed consent documents, they often have no way of knowing how the informed consent process is played out at the site. -
NCI provides ethical, legal guidelines for handling biospecimen resources
The National Cancer Institute (NCI) of Bethesda, MD, decided to address a deficit in quality of biospecimens collected for research purposes with the recent publication of improved recommendations. -
Interactive IC might provide education in entertaining way
IRBs and investigators continually look for ways to improve the informed consent (IC) process. One novel idea is to create an interactive informed consent program that serves a dual purpose of providing education to patients and trial participants.